Cure Alzheimer's Fund: Targeting Breakthrough Research

Research consortium member, Dr. Sam Gandy, has developed a new approach for studying brain synapses that has begun to yield valuable information about the production of Amyloid-Beta oligomers, known to play a role in the onset of Alzheimer's disease. By better understanding how Abeta clumping is re... (Read more)

Breakthrough research conducted by our very own Dr. Rudy Tanzi and his team at Massachusetts General Hospital has led to an important advancement in the understanding of the protein associated with Alzheimer’s disease. The prevailing theory has been that this protein -- A-beta -- has no function ... (Read more)

Testing the amyloid hypothesis of Alzheimer’s disease in vivo By Sam Gandy In this issue of The Lancet Neurology, Rinne and colleagues1 report something of a breakthrough by demonstrating the feasibility of eventually testing the so-called amyloid hypothesis of sporadic Alzheimer’s disease in v... (Read more)